Sfoglia per Rivista CANCER
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new-onset cytopenia
2014-01-01 Gozzetti, Alessandro; Defina, Marzia; Fabbri, Alberto
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment
2015-01-01 Cabanillas, Maria E; Schlumberger, Martin; Jarzab, Barbara; Martins, Renato G; Pacini, Furio; Robinson, Bruce; Mccaffrey, Judith C; Shah, Manisha H; Bodenner, Donald L; Topliss, Duncan; Andresen, Corina; O'Brien, James P; Ren, Min; Funahashi, Yasuhiro; Allison, Roger; Elisei, Rossella; Newbold, Kate; Licitra, Lisa F; Sherman, Steven I; Ball, Douglas W.
Physicians and end-of-life issues
2010-01-01 Gozzetti, Alessandro
Proper selection and classification criteria are necessary in the evaluation of the new TNM staging system for gastric cancer
2012-01-01 Marrelli, Daniele; Roviello, Franco
A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma
2014-01-01 Hamid, O.; Ilaria, Jr. R.; Garbe, C.; Wolter, P.; Maio, M.; Hutson, T. E.; Arance, A.; Lorigan, P.; Lee, J.; Hauschild, A.; Mohr, P.; Hahka-Kemppinen, M.; Kaiser, C.; Turner, P. K.; Conti, I.; Grob, J. -J.
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia
2007-01-01 Else, M.; Osuji, N.; Forconi, F.; Dearden, C.; Del Giudice, I.; Matutes, E.; Wotherspoon, A.; Lauria, F.; Catovsky, D.
Serum activin A and inhibin A.New clinical markers for hydatidiform mole
2002-01-01 Florio, P.; Severi, F. M.; Cobellis, L.; Danero, S.; Bome', A.; Luisi, S.; Petraglia, F.
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas
2012-01-01 Quaglino, P.; Pimpinelli, N.; Berti, E.; Calzavara-Pinton, P.; Alfonso Lombardo, G.; Rupoli, S.; Alaibac, M.; Bottoni, U.; Carbone, A.; Fava, P.; Fimiani, M.; Mamusa, A. M.; Titli, S.; Zinzani, P. L.; Bernengo, M. G.
Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma
2015-01-01 Fabbri, Alberto; Cencini, Emanuele; Bocchia, Monica
Urinary Calcium Excretion in the Monitoring of Bone Metastases from Prostatic Carcinoma
2002-01-01 Francini, Guido; Petrioli, R; Gonnelli, Stefano; Correale, P; Pozzessere, D; Marsili, S; Montagnani, A; Lucani, Barbara; Rossi, Stefania; Monaco, R; Manganelli, A; Salvestrini, F; Fiaschi, A. I.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new-onset cytopenia | 1-gen-2014 | Gozzetti, Alessandro; Defina, Marzia; Fabbri, Alberto | - | |
| A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment | 1-gen-2015 | Cabanillas, Maria E; Schlumberger, Martin; Jarzab, Barbara; Martins, Renato G; Pacini, Furio; Robinson, Bruce; Mccaffrey, Judith C; Shah, Manisha H; Bodenner, Donald L; Topliss, Duncan; Andresen, Corina; O'Brien, James P; Ren, Min; Funahashi, Yasuhiro; Allison, Roger; Elisei, Rossella; Newbold, Kate; Licitra, Lisa F; Sherman, Steven I; Ball, Douglas W. | - | |
| Physicians and end-of-life issues | 1-gen-2010 | Gozzetti, Alessandro | - | |
| Proper selection and classification criteria are necessary in the evaluation of the new TNM staging system for gastric cancer | 1-gen-2012 | Marrelli, Daniele; Roviello, Franco | - | |
| A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma | 1-gen-2014 | Hamid, O.; Ilaria, Jr. R.; Garbe, C.; Wolter, P.; Maio, M.; Hutson, T. E.; Arance, A.; Lorigan, P.; Lee, J.; Hauschild, A.; Mohr, P.; Hahka-Kemppinen, M.; Kaiser, C.; Turner, P. K.; Conti, I.; Grob, J. -J. | - | |
| The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia | 1-gen-2007 | Else, M.; Osuji, N.; Forconi, F.; Dearden, C.; Del Giudice, I.; Matutes, E.; Wotherspoon, A.; Lauria, F.; Catovsky, D. | - | |
| Serum activin A and inhibin A.New clinical markers for hydatidiform mole | 1-gen-2002 | Florio, P.; Severi, F. M.; Cobellis, L.; Danero, S.; Bome', A.; Luisi, S.; Petraglia, F. | - | |
| Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas | 1-gen-2012 | Quaglino, P.; Pimpinelli, N.; Berti, E.; Calzavara-Pinton, P.; Alfonso Lombardo, G.; Rupoli, S.; Alaibac, M.; Bottoni, U.; Carbone, A.; Fava, P.; Fimiani, M.; Mamusa, A. M.; Titli, S.; Zinzani, P. L.; Bernengo, M. G. | - | |
| Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma | 1-gen-2015 | Fabbri, Alberto; Cencini, Emanuele; Bocchia, Monica | - | |
| Urinary Calcium Excretion in the Monitoring of Bone Metastases from Prostatic Carcinoma | 1-gen-2002 | Francini, Guido; Petrioli, R; Gonnelli, Stefano; Correale, P; Pozzessere, D; Marsili, S; Montagnani, A; Lucani, Barbara; Rossi, Stefania; Monaco, R; Manganelli, A; Salvestrini, F; Fiaschi, A. I. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile